http://www.austpacresources.com/pdfs/misc/TheSpeculator18Jul2012.pdfNot sure I am very happy with the suggested completion time of early next year, but like the reference to a potential recovery stock.RT
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%